Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.63% |
| 5 | Energy | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
PUT
Alcoa
AA
$13.5B
| $556K | ﹤0.01% |
+16,400
| New | +$596K |
|
1202
Marathon Digital Holdings
MARA
$4.59B
| $554K | ﹤0.01% |
+40,000
| New | +$403K |
|
|
1203
CALL
Alcoa
AA
$13.5B
| $553K | ﹤0.01% |
+16,300
| New | +$592K |
|
1204
PUT
CVS Health
CVS
$119B
| $553K | ﹤0.01% |
8,000
| – | – |
|
1205
Huntsman Corp
HUN
$1.66B
| $548K | ﹤0.01% |
20,294
+17,951
| +766% | +$466K |
|
|
CTEV
1206
Claritev Corp
CTEV
$633M
| $548K | ﹤0.01% |
6,490
| – | – |
|
1207
CALL
Futu Holdings
FUTU
$17.7B
| $544K | ﹤0.01% |
13,700
+4,500
| +49% | +$191K |
|
1208
PUT
Citigroup
C
$224B
| $543K | ﹤0.01% |
11,800
-7,500
| -39% | -$351K |
|
1209
PUT
Honeywell
HON
$68.2B
| $540K | ﹤0.01% |
2,759
| – | – |
|
1210
CALL
Cencora
COR
$62.3B
| $539K | ﹤0.01% |
+2,800
| New | +$484K |
|
1211
PUT
ConocoPhillips
COP
$160B
| $539K | ﹤0.01% |
5,200
+1,800
| +53% | +$185K |
|
1212
Bristol-Myers Squibb
BMY
$139B
| $535K | ﹤0.01% |
+8,363
| New | +$561K |
|
1213
Chevron
CVX
$394B
| $528K | ﹤0.01% |
+3,356
| New | +$538K |
|
1214
Emcor
EME
$32.4B
| $526K | ﹤0.01% |
+2,846
| New | +$476K |
|
|
VNET
1215
VNET Group
VNET
$1.98B
| $522K | ﹤0.01% |
+180,100
| New | +$548K |
|
1216
Automatic Data Processing
ADP
$113B
| $520K | ﹤0.01% |
2,366
-2,835
| -55% | -$611K |
|
1217
Employers Holdings
EIG
$880M
| $520K | ﹤0.01% |
+13,900
| New | +$544K |
|
|
1218
PUT
Cencora
COR
$62.3B
| $520K | ﹤0.01% |
+2,700
| New | +$467K |
|
1219
PUT
Teck Resources
TECK
$34.9B
| $518K | ﹤0.01% |
12,300
| – | – |
|
1220
Synopsys
SNPS
$78B
| $515K | ﹤0.01% |
+1,183
| New | +$476K |
|
1221
Ares Management
ARES
$32.2B
| $514K | ﹤0.01% |
5,330
-229,970
| -98% | -$19.9M |
|
|
DBTX
1222
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $508K | ﹤0.01% |
132,000
| – | – |
|
1223
CALL
Martin Marietta Materials
MLM
$37.8B
| $508K | ﹤0.01% |
1,100
| – | – |
|
1224
Iridium Communications
IRDM
$4.99B
| $505K | ﹤0.01% |
+8,132
| New | +$503K |
|
1225
WEX
WEX
$6.81B
| $504K | ﹤0.01% |
2,766
+2,506
| +964% | +$444K |
|
Similar funds
Steven Cohen's Q2 2023 Portfolio in Review
As of Q2 2023, Steven Cohen held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Steven Cohen withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Micron Technology worth $178M.
- Steven Cohen's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Steven Cohen added most to Microsoft in Q2 2023, an estimated $431M increase.
- Steven Cohen's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Steven Cohen fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Steven Cohen's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Steven Cohen opened 772 new positions and closed 858 in Q2 2023.
- Steven Cohen's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.